7-76304099-C-G
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PM5PP3_ModeratePP5_Very_Strong
The NM_001540.5(HSPB1):c.544C>G(p.Pro182Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P182S) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001540.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease axonal type 2F Pathogenic:2
This sequence change replaces proline with alanine at codon 182 of the HSPB1 protein (p.Pro182Ala). The proline residue is highly conserved and there is a small physicochemical difference between proline and alanine. This variant is not present in population databases (ExAC no frequency). This variant has been observed to segregate with hereditary motor neuropathy in two families (PMID: 27816334, 29381233). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant disrupts the p.Pro182 amino acid residue in HSPB1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 18325928, 27816334, 29381233, 16155736, 25220807). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
4. The p.Pro182Ala variant in HSPB1 has already been described in the literature and is one of the three pathogenic variants at this amino acid residue (p.Pro182Leu and p.Pro182Ser). Patients usually present with an AD-CMT2F (OMIM: 606595) or an exclusively motor neuropathy (AD-dHMN2B; OMIM: 608634) with variable age of onset (6-54 years). ClinVar classifies this variant as Pathogenic (Variation ID: 946496), 1 star (criteria provided, 1 submission), citing 5 articles (29381233, 27816334, 25220807, 18325928 and 16155736). This variant is in a hotspot region and an important functional domain of the protein (C-terminal' anchoring motif'). This amino acid residue is highly conserved in different species. Besides that, this variant segregates with family phenotype. In summary, the p.Pro182Ala meets our criteria to be classified as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at